In the realm of advanced hepatobiliary oncology, a diagnosis of locally advanced, unresectable cholangiocarcinoma—especially with major vascular involvement—has historically been considered a clinical "dead end." However, a recent case from Sir Run Run Shaw Hospital (SRRSH) is challenging this status quo, demonstrating how a "Conversion Therapy" paradigm can successfully redefine treatment boundaries.